Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo
about
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.Single-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media: a double-blind, placebo-controlled, randomized clinical trial.Role of complement in host defense against pneumococcal otitis mediaSialic acid mediated transcriptional modulation of a highly conserved sialometabolism gene cluster in Haemophilus influenzae and its effect on virulence.Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adultsVaccines for Nontypeable Haemophilus influenzae: the Future Is Now.Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis mediaHigh-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis mediaVirulence of Streptococcus pneumoniae serotype 6C in experimental otitis mediaSingle-dose azithromycin for the treatment of children with acute otitis media.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Application of capillary electrophoresis mass spectrometry and liquid chromatography multiple-step tandem electrospray mass spectrometry to profile glycoform expression during Haemophilus influenzae pathogenesis in the chinchilla model of experimentClinical applications of azithromycin microspheres in respiratory tract infectionsVariation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale.The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid.Nontypeable Streptococcus pneumoniae as an otopathogenStudy design questions in treatment of children with acute otitis media.Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid.Effect of azithromycin on enhancement of methane production from waste activated sludge.
P2860
Q30301367-35A45CEB-1550-4368-B738-FC72ABE2323FQ30436538-DCE7FE08-5CAC-41E1-A0A5-50F32AED0F47Q33399371-629DF9E5-32D1-41D1-AF91-9EA1559DECBAQ33531531-4D3362E6-BD09-4D99-A189-2D2E382AB002Q34077164-6AAA7783-D8BC-444F-A11B-77BEA95D017EQ35548019-6E00D79D-5D48-4731-B191-43AEB4C33DF0Q35689035-F9736D2F-5680-4588-82A1-EEEA0E0B32C3Q35949905-5E06CF4A-9A75-436C-858B-C410BB213155Q36047763-8E49922D-5626-4C98-8A08-19CB4C686B22Q36055346-87273B56-BB4F-4B90-A3FA-7415F4059E8CQ36278035-6A58E603-E80F-479F-B745-19E43D181468Q36505518-48879463-89E3-4044-8780-AB4CF5F160E5Q36747215-99C5F646-735D-4B47-98D3-E5487C37EB5EQ37059889-54C8B8C3-1553-41B3-B864-09EC452F54D6Q37452035-34B9C4AE-E1C1-44A7-A60F-02C75918092DQ40840103-1AF46855-5B52-4950-9ECD-4751E623290FQ41765459-2E1625F1-977A-4159-AF7C-A882CDB53B3AQ41818536-61194717-F644-4998-A18A-5F421C91AF0CQ43188427-6BD75AF3-3070-43D5-A8CA-996D14A5E394Q46640276-D0836DAB-1D06-4C77-87AC-2065DE2121D7Q46699473-7ACD8E1C-B6C6-4C11-AD50-DDB29C984461Q46817696-CECFABDB-1B67-4BAE-9144-5D6C063D881EQ46898453-29608468-DD9C-46A2-9E8D-31A1DEF3EACF
P2860
Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Experimental acute otitis medi ...... zithromycin doses with placebo
@en
Experimental acute otitis medi ...... ithromycin doses with placebo.
@nl
type
label
Experimental acute otitis medi ...... zithromycin doses with placebo
@en
Experimental acute otitis medi ...... ithromycin doses with placebo.
@nl
prefLabel
Experimental acute otitis medi ...... zithromycin doses with placebo
@en
Experimental acute otitis medi ...... ithromycin doses with placebo.
@nl
P2093
P2860
P1476
Experimental acute otitis medi ...... zithromycin doses with placebo
@en
P2093
Franz E Babl
Stephen I Pelton
P2860
P304
P356
10.1128/AAC.46.7.2194-2199.2002
P407
P577
2002-07-01T00:00:00Z